Top 10 best performing biotech stocks of 2024 so far [Seeking Alpha]
Larimar Therapeutics, Inc. (LRMR)
Company Research
Source: Seeking Alpha
Additionally, the biotech sector is in 2024, outdoing all of the major market averages handedly. See the below breakdown of top performing biotech names in 2024: Top 10 Biotech Stocks YTD No. 10: Dianthus Therapeutics ( DNTH YTD. No. 9: Larimar Therapeutics ( LRMR YTD. No. 8: BiomX Inc ( PHGE YTD. No. 7: Mersana Therapeutics ( MRSN YTD. No. 6: Monopar Therapeutics ( NASDAQ: MNPR YTD. No. 5: Vera Therapeutics ( NASDAQ: VERA YTD. No. 4: Equillium ( NASDAQ: EQ YTD. No. 3: Ventyx Biosciences ( VTYX YTD. No. 2: Janux Therapeutics ( JANX YTD. No. 1: Elevation Oncology ( NASDAQ: ELEV YTD. For further analysis on the biotechnology industry, investors can look towards biotech focused exchange traded funds. See some popular funds listed below with each of their year-to-date performances. SPDR S&P Biotech ETF ( XBI YTD. iShares Biotechnology ETF ( IBB YTD. Invesco Biotechnology & Genome ETF ( PBE YTD. VanEck Biotech ETF ( BBH YTD. Direxion Daily S&P Biotech Bu
Show less
Read more
Impact Snapshot
Event Time:
LRMR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LRMR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LRMR alerts
High impacting Larimar Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LRMR
News
- Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.MarketBeat
- Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $25.00 price target on the stock.MarketBeat
- Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $25.00 price target on the stock.MarketBeat
- Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development [Yahoo! Finance]Yahoo! Finance
- Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp DevelopmentGlobeNewswire
LRMR
Earnings
- 3/14/24 - Miss
LRMR
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- 4/12/24 - Form PRE
- LRMR's page on the SEC website